Cradle
PrivateLast Round
Series B
Nov 26, 2024
Total Funding Raised
$102.4M
Company Overview
Cradle operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Series B round in November 2024.
Cradle is a biotechnology company that develops an enterprise-grade AI software platform designed to accelerate protein engineering for pharmaceutical, industrial, and food-tech sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cradle Comparables
Compare Cradle with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Levitate | 83% | |
| OpenProtein.AI | 81% | |
| abYcloud | 78% |
For institutional investors. Book with your work email.
Cradle Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 26, 2024 | ||||
| Series A | Nov 28, 2023 | ||||
| Seed | Nov 17, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cradle Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amino Collective | Seed |
| Kindred Capital | Seed, Series A, Series B |
| Institutional Venture Partners (IVP) | Series B |
| Index Ventures | Series B, Seed, Series A |
| Sir Nelson Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Marcus Schindler joins the Advisory Board, recruited by Occam Global.
- Feb 24, 2026
Added Argenx, a biotechnology company, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientNov 3, 2026
On Nov 3rd '26, Cradle signs UCB as a client to provide access to its protein-design platform and AI models, initially supporting as many as three drug programs with potential to expand across the pipeline.
For institutional investors. Book with your work email.
Cradle Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cradle's valuation, stock price, and market status.
Is Cradle a public or private company?
Cradle is a private company.
What is the current stock price of Cradle?
Cradle is a private company, so its shares have no public market price. Caplight tracks Cradle's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cradle worth (valuation)?
Valuation information for Cradle is not publicly available.
Can I buy Cradle stock?
Cradle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cradle's last funding round?
Cradle's most recent funding round was Series B on November 26, 2024.
Who are the main investors in Cradle?
Key investors in Cradle include Kindred Capital, Institutional Venture Partners (IVP), Index Ventures.
Will Cradle IPO soon?
No public IPO plans have been announced for Cradle.
How can I track Cradle secondary market activity?
Caplight tracks bids, offers, and trades in Cradle's shares on secondary markets.